Secondary Efficacy Endpoint: Mean Clinical & Patient Global Impression of Change at Week 4 (CGI-C & PGI-C)

Secondary Efficacy Endpoint: Mean Clinical & Patient Global Impression of Change at Week 4 (CGI-C & PGI-C)

CGI-C reflects the physician’s perception of the patient’s health status by rating the patient on a 7-point scale from “very much improved” (a score of 1) to “very much worse” (a score of 7). Similarly, PGI-C enables the patient to rate their changes on the same scale. The Clinicians Global Impression of Change (CGI-C) was highly statistically significant at all three dose levels, as was the Patients Global Impression of Change (PGI-C).

Format

PNG

Source

AEON Biopharma

Downloads